51763
47672
S&P/TSX
15452.64
+44.98
(0.29%)
S&P-CDNX
830.17
-4.03
(-0.48%)
S&P-500
2732.22
+1.02
(0.04%)
NASDAQ
7239.47
-16.96
(-0.23%)
Dow
25219.38
+19.01
(0.08%)
Dollar
0.7944
-0.00190
(-0.239%)
Oil
62.33
+0.78
(+1.27%)
Gold
1350.30
-5.90
(-0.44%)
Silver
16.650
-0.062
(-0.37%)


Valeant to sell Obagi

Valeant Pharmaceuticals International, Inc. (TSX:VRX) has a deal to sell its Obagi skin care business to a Hong Kong-based group for US$190 million in cash.

The Quebec-based company, headquartered in Laval, estimates its Obagi Medical Products unit will generate about US$85 million of revenue in 2017.

The buyer is a fund managed by a limited partnership that includes China Regenerative Medicine International and Haitong International Securities Group, both headquartered in Hong Kong.



More Business News

49169
Recent Trending
51806
Okanagan Oldies
Castanet Proud Member of RTNDA Canada
Press Room